Dan Rosenberg is a Chicago-area writer who previously reported for Dow Jones Newswires and The Wall Street Journal, covering financial markets and health care companies. He also spent six years as spokesman for Hospira Inc., a pharmaceutical company bought by Pfizer in 2015.
